Iu, L., Zhao, P., Yeung, I., Fung, N., Lee, J., Wong, R., . . . Wong, I. (2014). Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion. BMJ Publishing Group.
Cytowanie według stylu Chicago (wyd. 17)Iu, L., P. Zhao, I. Yeung, N. Fung, J. Lee, R. Wong, V. Chong, i I. Wong. Sequential Therapy with Ranibizumab and Dexamethasone Intravitreal Implant Is Better than Dexamethasone Monotherapy for Macular Oedema Due to Retinal Vein Occlusion. BMJ Publishing Group, 2014.
Cytowanie według stylu MLA (wyd. 9)Iu, L., et al. Sequential Therapy with Ranibizumab and Dexamethasone Intravitreal Implant Is Better than Dexamethasone Monotherapy for Macular Oedema Due to Retinal Vein Occlusion. BMJ Publishing Group, 2014.